Retatrutide works as a triple receptor agonist, targeting three key hormonal pathways simultaneously: [1] [4] GLP-1 (glucagon-like peptide-1): Is thought to reduce appetite and slow gastric emptying GIP (glucose-dependent insulinotropic polypeptide): Is thought to enhance insulin secretion and may influence fat metabolism, though human evidence remains limited Glucagon receptor: Has been observed in early studies to increase energy expenditure and promote fat breakdown, though the clinical significance in humans is still being established This triple-action mechanism distinguishes retatrutide from currently approved dual or single agonists
Sustained delivery of MGF peptide from microrods attracts stem cells and reduces apoptosis of myocytes
Alcohol consumption on DSIP nights is inadvisable, as alcohol already disrupts sleep architecture and combining it with DSIPs effects creates unpredictable outcomes
By boosting collagen production and activating stem cells, GHK-Cu enhances skin elasticity, strengthens the skin barrier, and restores skin appearance
Research-grade BPC-157 is manufactured for laboratory use without pharmaceutical sterility, potency verification, or quality control standards